Health Matters: Decoding Immunity to COVID-19
MUHC Foundation Health Matters interview with Bruce Mazer discusses findings and unanswered questions about decoding immunity to COVID-19
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
MUHC Foundation Health Matters interview with Bruce Mazer discusses findings and unanswered questions about decoding immunity to COVID-19
Dr. Nicole Ezer discusses progress made by the medical community in finding optimal treatments for COVID-19.
MUHC Foundation Health Matters interview with Dao Nguyen to discuss the critical need for research into infectious diseases
Congratulations to Dr. Nargis Khan and Jeffrey Downey from the Divangahi lab on their recent publication in Cell!
Dr. McCusker won the Montreal Children’s Hospital Foundation 2020 Pfizer Research Award of Excellence.
Could Dr. Divangahi’s expertise in innate disease tolerance be applied to the SARS CoV-2 virus, enabling us to co-exist?
Dr. Divangahi discusses ongoing studies that examine whether flu vaccines may inhibit COVID-19.
Dr. Nicole Ezer of the RI-MUHC’s RESP Program is researching treatment options for COVID-19.
McGill Research Centre for Cannabis, led by Dr. Carolyn Baglole, establishes a CBD Research Partnership Fund with AQIC
MUHC Foundation Health Matters interview with Carolyn Baglole on how legalization of cannabis had a positive impact on research